Stock DUA DUALITY S.A.
Add to a list
To use this feature you must be a member
Log inSign up

News Duality S.A.

Equities

DUA

PLDLITY00010

End-of-day quote Warsaw S.E.
Other stock markets
 18:00:00 2024-06-30 EDT 		5-day change 1st Jan Change
1.515 PLN -0.33% Intraday chart for Duality S.A. -0.98% +2.36%
05-15 Duality S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-20 Duality S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Duality S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Duality S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
BioNTech to Present Clinical Data Updates on Cancer Vaccine Candidates
MT
Tod's CEO says he has no plans to sell 'family business'
RE
BioNTech, Duality Biologics Obtain FDA Fast Track Designation for Ovarian Cancer Therapy Candidate
MT
BioNTech's Cancer Therapy Candidate Obtains Fast-track Designation from US FDA
MT
BioNTech, Duality Biologics Initiate Phase 3 Trial of Breast Cancer Drug
MT
BioNTech Begins Late-stage Study for Metastatic Breast Cancer Therapy Candidate
MT
BioNTech challenges AstraZeneca with breast cancer precision drug trial
RE
BioNTech, Duality Biologics Get US FDA Breakthrough Therapy Designation for Uterine Cancer Drug Candidate
MT
Duality S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Australia's Albanese to highlight trade on China visit as ties warm
RE
Duality S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Introducing Janus, the exotic 'two-faced' white dwarf star
RE
HBM Holdings, Beigene Sign License Deal for Antibody-Drug Conjugate Program; HBM Shares Soar 20%
MT
Duality S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
BioNTech, DualityBio Sign Strategic Partnership to Develop ADC Therapeutics to Treat Solid Tumors
MT
BioNTech Partners With DualityBio to Develop Cancer Treatments
MT
BioNTech, Duality Biologics Enter Licensing Agreement for Cancer Treatments
DJ
Credit Suisse on Hydro One: "All About Ontario with the Duality of Delivering Decarbonization and Defensive Growth"
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DUA Stock
  4. News Duality S.A.